Hoteles Bestprice: capital increase of up to €10.3 million, subscription period from 11 November to 1 December
Shareholders of Hoteles Bestprice will be able to exercise their pre-emptive subscription rights from 11 November to 1 December 2026. This timetable follows the publication, on 10 November 2026, of the announcement of the capital increase in the Boletín Oficial del Registro Mercantil (BORME), the official gazette of the Spanish commercial register.
The transaction, amounting to up to €10.3 million, was approved on 3 November 2026 by the board of directors of the Spanish economy hotel chain, under the authorisation of the general meeting held on 22 June 2026.
Subscription, trading of rights, then discretionary allocation
In accordance with Article 503 of the Spanish Capital Companies Act, the pre-emptive subscription period opens on the first business day following publication in the BORME and runs for twenty-one calendar days. It will therefore begin on 11 November 2026 and end on 1 December 2026.
The company will request the admission to trading of the pre-emptive subscription rights on Euronext Access Paris during the first five trading days of this period, i.e. from 11 to 17 November 2026. This listing remains subject to the approval of Euronext Access Paris and to the publication of a transaction notice on securities.
A discretionary allocation period of ten business days will follow, from 2 to 16 December 2026. It may be extended by ten additional days, or closed early if the capital increase is fully subscribed before its end.
A deed filed on 6 November, a result published at closing
From a legal standpoint, the notarial deed recording the decision to increase capital was signed on 6 November 2026, pursuant to Article 508, paragraph 1, of the Spanish Capital Companies Act. It was filed with the commercial register the same day.
Upon completion of the transaction, Hoteles Bestprice will announce to the market the number of shares subscribed, the final amount of the increase and the resulting share capital. A second deed, relating to the execution of the capital increase, will then be signed under Article 508, paragraph 2.
The board of directors meeting on 27 October 2026 had also adopted several decisions relating to the process of admitting the company's shares to the BME Growth segment of BME MTF Equity.
